Catalyst Wire Dossier Catalyst Wire Dossier

Vyvanse

lisdexamfetamine dimesylate · Takeda
Drug timelines are a Plus or Pro feature.

74 regulatory and trial events tracked for Vyvanse, covering 2007-02-23 to 2026-04-23. Get the full timeline:

Most recent: FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing